Skip to main content
Equibles
PDSB logo

PDSB · PDS Biotechnology Corp

Track PDSB — free

Use PDSB with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about PDSB

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.23 0.00 (-1.11%) At close · Aug 14
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result of these uncertainties, the Company has concluded that substantial doubt exists about the Company's ability to continue as a going concern for a period of at least 12 months from the date of the issuance of these unaudited Condensed Consolidated Financial Statements.”
View the 10-Q filed Aug 13, 2026
Market Cap
$13.51M
Shares
55.97M

PDS Biotechnology Corp Earnings Call Transcripts

Every quarterly earnings call for PDS Biotechnology Corp (PDSB) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY25 · Q4
2026-05-13
PDS Biotechnology Corp Q4 FY2025 Earnings Call
Confident tone VERSATILE-002 Phase II data VERSATILE-003 Phase III protocol amendment Unmet need in HPV16-positive head and neck cancer
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q1
2026-05-13
PDS Biotechnology Corp Q1 FY2026 Earnings Call
Confident tone PDS01ADC in prostate and colorectal cancer PDS0101 for HPV16-positive head and neck cancer Manufacturing and CMC readiness for BLA
Diluted EPS
$-0.13
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q3
2025-11-12
PDS Biotechnology Corp Q3 FY2025 Earnings Call
Confident tone VERSATILE-003 Protocol Amendment VERSATILE-002 Final Data PDS0101 Lead Asset
Diluted EPS
$-0.19
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
PDS Biotechnology Corp Q2 FY2025 Earnings Call
Confident tone HPV16-Positive Head and Neck Cancer Opportunity VERSATILE-003 Phase III Trial VERSATILE-002 Phase II Data
Diluted EPS
$-0.21
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
PDS Biotechnology Corp Q1 FY2025 Earnings Call
Confident tone VERSATILE 003 Phase 3 trial initiation ASCO 2025 data presentations Keynote 689 / standard of care impact
Diluted EPS
$-0.21
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-27
PDS Biotechnology Corp Q4 FY2024 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-14
PDS Biotechnology Corp Q3 FY2024 Earnings Call
Confident tone HPV-positive head and neck cancer opportunity VERSATILE-003 Phase 3 trial design update VERSATILE-002 updated efficacy and durability data
Diluted EPS
$-0.29
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-27
PDS Biotechnology Corp Q4 FY2023 Earnings Call
Confident tone Triple combination strategy in head and neck cancer Drug platform technology and mechanism of action Shift away from VERSATILE-003
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-14
PDS Biotechnology Corp Q3 FY2023 Earnings Call
Diluted EPS
$-0.35
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
PDS Biotechnology Corp Q2 FY2023 Earnings Call
Diluted EPS
$-0.37
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
PDS Biotechnology Corp Q1 FY2023 Earnings Call
Diluted EPS
$-0.32
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-28
PDS Biotechnology Corp Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-14
PDS Biotechnology Corp Q3 FY2022 Earnings Call
Diluted EPS
$-0.26
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
PDS Biotechnology Corp Q2 FY2022 Earnings Call
Diluted EPS
$-0.20
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
PDS Biotechnology Corp Q1 FY2022 Earnings Call
Diluted EPS
$-0.32
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-15
PDS Biotechnology Corp Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
PDS Biotechnology Corp Q3 FY2021 Earnings Call
Diluted EPS
$-0.24
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
PDS Biotechnology Corp Q2 FY2021 Earnings Call
Diluted EPS
$-0.03
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
PDS Biotechnology Corp Q1 FY2021 Earnings Call
Diluted EPS
$-0.14
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-18
PDS Biotechnology Corp Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-12
PDS Biotechnology Corp Q3 FY2020 Earnings Call
Diluted EPS
$-0.21
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
PDS Biotechnology Corp Q2 FY2020 Earnings Call
Diluted EPS
$-0.19
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-13
PDS Biotechnology Corp Q1 FY2020 Earnings Call
Diluted EPS
$-0.39
Audio Transcript Slides 8-K10-Q
Showing 1–23 of 23 earnings calls
Key facts CIK 1472091 CUSIP 70465T107 13F (30d) 49 filings 49 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)